Abbott Laboratories (ABT)
102.61
+0.38
(+0.37%)
USD |
NYSE |
Sep 18, 16:00
102.93
+0.32
(+0.31%)
After-Hours: 20:00
Abbott Laboratories Enterprise Value : 205.21B for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 205.21B |
| September 17, 2026 | 204.55B |
| September 16, 2026 | 204.78B |
| September 15, 2026 | 204.21B |
| September 14, 2026 | 206.04B |
| September 11, 2026 | 204.07B |
| September 10, 2026 | 206.51B |
| September 09, 2026 | 209.75B |
| September 08, 2026 | 210.25B |
| September 04, 2026 | 215.11B |
| September 03, 2026 | 215.91B |
| September 02, 2026 | 218.81B |
| September 01, 2026 | 216.15B |
| August 31, 2026 | 218.62B |
| August 28, 2026 | 222.27B |
| August 27, 2026 | 220.75B |
| August 26, 2026 | 225.09B |
| August 25, 2026 | 228.61B |
| August 24, 2026 | 229.54B |
| August 21, 2026 | 229.49B |
| August 20, 2026 | 225.16B |
| August 19, 2026 | 225.66B |
| August 18, 2026 | 222.64B |
| August 17, 2026 | 218.64B |
| August 14, 2026 | 220.16B |
| Date | Value |
|---|---|
| August 13, 2026 | 220.20B |
| August 12, 2026 | 219.57B |
| August 11, 2026 | 217.51B |
| August 10, 2026 | 215.61B |
| August 07, 2026 | 214.21B |
| August 06, 2026 | 214.47B |
| August 05, 2026 | 210.58B |
| August 04, 2026 | 210.14B |
| August 03, 2026 | 213.02B |
| July 31, 2026 | 210.56B |
| July 30, 2026 | 210.40B |
| July 29, 2026 | 214.54B |
| July 28, 2026 | 213.28B |
| July 27, 2026 | 208.46B |
| July 24, 2026 | 205.99B |
| July 23, 2026 | 201.99B |
| July 22, 2026 | 201.68B |
| July 21, 2026 | 200.12B |
| July 20, 2026 | 203.57B |
| July 17, 2026 | 201.87B |
| July 16, 2026 | 198.67B |
| July 15, 2026 | 182.13B |
| July 14, 2026 | 181.59B |
| July 13, 2026 | 187.04B |
| July 10, 2026 | 190.19B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Becton, Dickinson & Co. | 65.23B |
| Boston Scientific Corp. | 74.92B |
| DexCom, Inc. | 33.17B |
| Globus Medical, Inc. | 9.462B |
| Intuitive Surgical, Inc. | 134.08B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 928.00M |
| Revenue (Quarterly) | 12.59B |
| Total Expenses (Quarterly) | 11.66B |
| EPS Diluted (Quarterly) | 0.5324 |
| Gross Profit Margin (Quarterly) | 52.64% |
| Profit Margin (Quarterly) | 7.37% |
| Earnings Yield | 3.02% |
| Operating Earnings Yield | 4.27% |
| Normalized Earnings Yield | 3.039 |